Atul Saran - Feb 23, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Strat & Dev Officer
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 23, 2023
Transactions value $
-$16,804
Form type
4
Date filed
2/27/2023, 07:23 PM
Previous filing
Feb 10, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$5.22K -365 -0.41% $14.30 88.5K Feb 23, 2023 Direct F1
transaction EBS Common Stock Tax liability -$11.6K -845 -0.96% $13.71 87.6K Feb 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.